401(k) · DOL Form 5500 · 2023

Ipsen Biopharmaceuticals, Inc 401(k) Plan

Data updated 2026-08-25

$166M
Total assets Near avg plan size
622
Participants Below avg headcount
94th
Percentile by assets National rank
$266,693
Avg per participant High balance/head
PlainRetire home → About this data RSS: change history

Official DOL plan name: Ipsen Biopharmaceuticals, Inc. U.S. 401(k) Plan · Sponsored by Ipsen Biopharmaceuticals, Inc · New Jersey · Wholesale Trade

$166M in assets, 622 participants

Ipsen Biopharmaceuticals, Inc's Ipsen Biopharmaceuticals, Inc. U.S. 401(k) Plan reported $166M in total assets and 622 participants in its 2023 DOL Form 5500 filing, ranking in the 94th percentile by assets among filed plans. Figures are as reported by the plan sponsor to the Department of Labor, not audited or endorsed by PlainRetire.

  • #6,017 in Wholesale Trade (6,309 peers)

Where Ipsen Biopharmaceuticals, Inc. U.S. 401(k) Plan sits by assets

Ipsen Biopharmaceuticals, Inc. U.S. 401(k) Plan sits in the top 10% of all filed plans by assets, $166M for 622 participants (~$266,693/participant), up 32.7% in 2023.

#6,017
in Wholesale Trade (6,309 peers)
+32.7%
assets growth YoY
1.7×
vs typical plan assets (national mean)

Ipsen Biopharmaceuticals, Inc. U.S. 401(k) Plan's outsized position by total assets

Ipsen Biopharmaceuticals, Inc. U.S. 401(k) Plan vs every filed plan by assets

End-of-year total assets · plan year 2023 · DOL Form 5500

$165,883,134 Top 6% higher than 94% of 127,068 filed plans

This plan $0 $2,050,000,000 every filed plan with reported assets, bucketed by value

Dashed line + filled bar = this entry, among filed plans.

Source U.S. Department of Labor Form 5500 filings (EBSA) · plan year 2023

Ipsen Biopharmaceuticals, Inc. U.S. 401(k) Plan among mid-size filed plans by headcount

Plan-year 2023 Form 5500 filings with a reported participant count, partitioned by headcount band, not by assets. Ipsen Biopharmaceuticals, Inc. U.S. 401(k) Plan sits mid-pack in the medium band (622 participants).

What changed between DOL Form 5500 filings

plan year 2022 → plan year 2023

  • Ipsen Biopharmaceuticals, Inc. U.S. 401(k) Plan reported net income rose from -$10M in the plan year 2022 filing to $41M in the plan year 2023 filing.
  • Ipsen Biopharmaceuticals, Inc. U.S. 401(k) Plan end-of-year assets rose from $125M in the plan year 2022 filing to $166M in the plan year 2023 filing.
  • Ipsen Biopharmaceuticals, Inc. U.S. 401(k) Plan reported participants rose from 505 in the plan year 2022 filing to 622 in the plan year 2023 filing.

See the national 2022→2023 release diff →

Form 5500 schedule snapshot

Filing strip 260042539 · Ipsen Biopharmaceuticals, Inc PY 2023 · 401(k)

Ipsen Biopharmaceuticals, Inc. U.S. 401(k) Plan · $166M · 622 · 94th

  • PART $166M
  • TYPE 622
  • NET 94th
  • BOOK 401(k)
  • VS-ST near Moelis & Company Group LP 401(k) Profit Sharing Plan
  • BOY ind #6017

Stamps derive from this plan's Form 5500 line items (assets, participants, type, EIN, cohort placement) - not a quality rating of the sponsor. Read with Wholesale Trade retirement plans → · Plans in New Jersey →

Ipsen Biopharmaceuticals, Inc. U.S. 401(k) Plan in the asset neighbourhood

Fj Management Inc. 401(k) PlanFj Management Inc. 401(k) Pl…$166MIpsen Biopharmaceuticals, Inc. U.S. 401(k) PlanIpsen Biopharmaceuticals, In…$166MMoelis & Company Group LP 401(k) Profit Sharing PlanMoelis & Company Group LP 40…$166MCmt Profit Sharing/401(k) PlanCmt Profit Sharing/401(k) Pl…$166MHomestreet, Inc 401(k) Savings PlanHomestreet, Inc 401(k) Savin…$166M
End-of-year total assets ($M) among Ipsen Biopharmaceuticals, Inc. U.S. 401(k) Plan and nearest nationwide 401(k) peers. Source: DOL Form 5500 plan year 2023.

Scale-class filing particulars (2023)

Total Assets (Beginning of Year)$125M
Net Assets (End of Year)$166M
Net Income$41M
Employer EIN260042539
Plan Effective Date2005-01-01
Filing StatusFILING RECEIVED

Sponsor Plan History (Ipsen Biopharmaceuticals, Inc)

Sponsor-wide plan assets over time

All Ipsen Biopharmaceuticals, Inc plans reported in each filing year

Latest sponsor-wide plan assets
$206M 64.62247117274728% vs 2022
2024 filing year
$100M$150M$200M$250M 202220232024 $125M $206M ▲ +64.6%
Year Plans Participants Total Assets
2022 1 505 $125M
2023 1 622 $166M
2024 1 692 $206M

Nearby 401(k) Plans in New Jersey

Peer 401(k) plans, same state, same plan type, ranked by total assets.

Ipsen Biopharmaceuticals, Inc. U.S. 401(k) Plan vs. nearby 401(k) plans in New Jersey, assets vs. participants Scatter plot of 6 data points. -50000050000100000150000200000 -1001020304050 Total assets ($B) Participants Ipsen Biopharmaceuticals, Inc. U.S. 401(k) Plan, Total assets ($B): 0.165883134 · Participants: 622Ipsen Biopharmaceuticals, Inc. U.S. 401(k) PlanJPMorgan Chase 401(k) Savings Plan, Total assets ($B): 44.552237022 · Participants: 176610JPMorgan Chase 401(k) Savings PlanVerizon Savings Plan for Management Employees, Total assets ($B): 27.825640157 · Participants: 78072Verizon Savings Plan for Management EmployeesJohnson and Johnson Savings Plan, Total assets ($B): 22.177853595 · Participants: 41291Johnson and Johnson Savings PlanErnst & Young Retirement Savings Plan, Total assets ($B): 15.543526764 · Participants: 59346Ernst & Young Retirement Savings PlanMerck US Savings Plan, Total assets ($B): 13.424416176 · Participants: 26850Merck US Savings Plan
Ipsen Biopharmaceuticals, Inc. U.S. 401(k) Plan vs. nearby 401(k) plans in New Jersey, assets vs. participants
Compare Ipsen Biopharmaceuticals, Inc. U.S. 401(k) Plan side-by-side with 3 peers →

Ipsen Biopharmaceuticals, Inc. U.S. 401(k) Plan's out-of-state 401(k) peers by assets and headcount

Outside New Jersey, the nearest 401(k) by assets is Moelis & Company Group LP 401(k) Profit Sharing Plan in NY ($166M); by covered participants it is Telamon Corporation 401(k) Plan in IN (622 participants). Same-state nearby plans are listed separately above.

Closest by plan assets

Nearest other-state filings by tot_assets_eoy ($166M here).

Similar participant headcount

Nearest other-state filings by covered participants (622 participants); asset peers above are excluded.

DOL Form 5500 plan year 2023. Asset totals can differ widely at the same headcount; neither axis is a quality rating.

Frequently Asked Questions

How did Ipsen Biopharmaceuticals, Inc. U.S. 401(k) Plan assets move in 2023? ▼
Ipsen Biopharmaceuticals, Inc. U.S. 401(k) Plan surged - up 32.7% during 2023, from $125M to $166M. Reported net income was $41M.
How have Ipsen Biopharmaceuticals, Inc plan assets changed over time? ▼
Across 3 plan years on file (2022-2024), Ipsen Biopharmaceuticals, Inc's sponsor-wide assets grew 64.6%, from $125M to $206M.
Where does Ipsen Biopharmaceuticals, Inc. U.S. 401(k) Plan rank by assets among Form 5500 filers? ▼
Ipsen Biopharmaceuticals, Inc. U.S. 401(k) Plan ranks in the 94th percentile by end-of-year assets among 127,072 plans that reported assets for plan year 2023 (in the top 10% of all filed plans by assets).
Which 401(k) plans are similar in size to Ipsen Biopharmaceuticals, Inc. U.S. 401(k) Plan? ▼
Among 401(k) plans in other states, the closest by assets is Moelis & Company Group LP 401(k) Profit Sharing Plan in NY ($166M, 806 participants).
Which 401(k) plans cover a similar participant headcount to Ipsen Biopharmaceuticals, Inc. U.S. 401(k) Plan? ▼
Among 401(k) plans in other states, the closest by covered participants is Telamon Corporation 401(k) Plan in IN (622 participants, $42M in assets).

Source: U.S. Department of Labor, Employee Benefits Security Administration (EBSA), Form 5500 public disclosure dataset. Plan year 2023.

Source: DOL EFAST2 filing system (efast.dol.gov) - original filing retrieval by EIN 260042539.

Read our methodology - how this data is sourced, computed, and verified.

Data sourced from U.S. Department of Labor Form 5500 filings (EBSA). See our methodology for details.